Angiokeratomas

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Angiokeratomas trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 2 trials

RecruitingNot Applicable

NCT00196742

Fabry Disease Registry & Pregnancy Sub-registry

The Fabry Registry is an ongoing, international multi-center, strictly observational program that tracks the routine clinical outcomes for patients with Fabry d…

United States9,000 participantsStarted 2001-07-31

RecruitingPhase 2

NCT07552077

A Phase 2, Baseline-Controlled Study Evaluating the Safety and Efficacy of PTX-022 (Sirolimus) Topical Gel 3.9% in the T…

The purpose of this study is to evaluate the safety and effectiveness of the experimental drug PTX-022 in the treatment of angiokeratomas

United States15 participantsStarted 2026-04

Treatment: PTX-022

All recent trials (4 shown)

CompletedNot Applicable

NCT04804566

Understanding Fabry Disease Therapy Choices Through the Eyes of the Patients

The objective of this study is to increase the understanding surrounding the choices presented to patients and families impacted by Fabry disease.

United States44 participantsStarted 2023-03-01

Treatment: This is a non-interventional study

WithdrawnNot Applicable

NCT02778295

Biomarker for Patients With Fabry Disease (BioFabry)

Development of a new mass spectrography-based biomarker for the early and sensitive diagnosis of Fabry disease from the blood

Germany, India, Sri Lanka0Started 2018-08-20